nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—AR—Medroxyprogesterone Acetate—uterine cancer	0.22	0.298	CbGbCtD
Flutamide—AR—Progesterone—uterine cancer	0.146	0.197	CbGbCtD
Flutamide—CYP1B1—Progesterone—uterine cancer	0.126	0.171	CbGbCtD
Flutamide—CYP1A1—Progesterone—uterine cancer	0.0552	0.0749	CbGbCtD
Flutamide—CYP1B1—Doxorubicin—uterine cancer	0.0384	0.0521	CbGbCtD
Flutamide—CYP3A5—Progesterone—uterine cancer	0.0331	0.0449	CbGbCtD
Flutamide—CYP2C19—Progesterone—uterine cancer	0.0267	0.0362	CbGbCtD
Flutamide—CYP1A2—Progesterone—uterine cancer	0.0247	0.0334	CbGbCtD
Flutamide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0195	0.0265	CbGbCtD
Flutamide—CYP3A5—Etoposide—uterine cancer	0.0148	0.0201	CbGbCtD
Flutamide—CYP3A4—Progesterone—uterine cancer	0.0129	0.0175	CbGbCtD
Flutamide—CYP1A2—Etoposide—uterine cancer	0.011	0.015	CbGbCtD
Flutamide—CYP3A4—Etoposide—uterine cancer	0.00578	0.00784	CbGbCtD
Flutamide—AR—semen—uterine cancer	0.00543	0.0983	CbGeAlD
Flutamide—AR—oviduct—uterine cancer	0.00398	0.0721	CbGeAlD
Flutamide—CYP3A4—Doxorubicin—uterine cancer	0.00395	0.00535	CbGbCtD
Flutamide—AHR—myometrium—uterine cancer	0.00258	0.0468	CbGeAlD
Flutamide—AHR—uterine cervix—uterine cancer	0.00201	0.0364	CbGeAlD
Flutamide—AHR—smooth muscle tissue—uterine cancer	0.00195	0.0354	CbGeAlD
Flutamide—AHR—decidua—uterine cancer	0.00192	0.0347	CbGeAlD
Flutamide—AHR—endometrium—uterine cancer	0.00182	0.0329	CbGeAlD
Flutamide—AHR—mammalian vulva—uterine cancer	0.00176	0.0318	CbGeAlD
Flutamide—AHR—uterus—uterine cancer	0.00168	0.0303	CbGeAlD
Flutamide—AHR—female reproductive system—uterine cancer	0.00151	0.0273	CbGeAlD
Flutamide—AHR—female gonad—uterine cancer	0.00137	0.0248	CbGeAlD
Flutamide—AHR—vagina—uterine cancer	0.00136	0.0247	CbGeAlD
Flutamide—AR—myometrium—uterine cancer	0.00127	0.0231	CbGeAlD
Flutamide—CYP1B1—smooth muscle tissue—uterine cancer	0.00102	0.0184	CbGeAlD
Flutamide—AR—epithelium—uterine cancer	0.001	0.0181	CbGeAlD
Flutamide—CYP1B1—decidua—uterine cancer	0.000998	0.0181	CbGeAlD
Flutamide—AR—uterine cervix—uterine cancer	0.000992	0.018	CbGeAlD
Flutamide—CYP1B1—renal system—uterine cancer	0.00098	0.0177	CbGeAlD
Flutamide—AR—smooth muscle tissue—uterine cancer	0.000964	0.0174	CbGeAlD
Flutamide—Menopausal symptoms—Progesterone—uterine cancer	0.000953	0.0069	CcSEcCtD
Flutamide—AR—decidua—uterine cancer	0.000945	0.0171	CbGeAlD
Flutamide—Diabetes mellitus—Medroxyprogesterone Acetate—uterine cancer	0.000937	0.00679	CcSEcCtD
Flutamide—AR—renal system—uterine cancer	0.000928	0.0168	CbGeAlD
Flutamide—Ulcer—Dactinomycin—uterine cancer	0.000926	0.0067	CcSEcCtD
Flutamide—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000903	0.00654	CcSEcCtD
Flutamide—Bullous eruption—Epirubicin—uterine cancer	0.000899	0.00651	CcSEcCtD
Flutamide—AR—endometrium—uterine cancer	0.000897	0.0162	CbGeAlD
Flutamide—Interstitial lung disease—Etoposide—uterine cancer	0.000896	0.00648	CcSEcCtD
Flutamide—Disturbance in sexual arousal—Progesterone—uterine cancer	0.000893	0.00646	CcSEcCtD
Flutamide—AHR—lymph node—uterine cancer	0.000881	0.0159	CbGeAlD
Flutamide—Libido decreased—Medroxyprogesterone Acetate—uterine cancer	0.000879	0.00636	CcSEcCtD
Flutamide—CYP1B1—uterus—uterine cancer	0.000873	0.0158	CbGeAlD
Flutamide—Hot flush—Medroxyprogesterone Acetate—uterine cancer	0.000871	0.00631	CcSEcCtD
Flutamide—Increased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000868	0.00628	CcSEcCtD
Flutamide—AR—mammalian vulva—uterine cancer	0.000867	0.0157	CbGeAlD
Flutamide—Menopausal symptoms—Medroxyprogesterone Acetate—uterine cancer	0.000864	0.00625	CcSEcCtD
Flutamide—Laboratory test abnormal—Epirubicin—uterine cancer	0.000851	0.00616	CcSEcCtD
Flutamide—Bullous eruption—Doxorubicin—uterine cancer	0.000832	0.00602	CcSEcCtD
Flutamide—AR—uterus—uterine cancer	0.000826	0.015	CbGeAlD
Flutamide—Aspartate aminotransferase increased—Progesterone—uterine cancer	0.00081	0.00586	CcSEcCtD
Flutamide—Disturbance in sexual arousal—Medroxyprogesterone Acetate—uterine cancer	0.000809	0.00585	CcSEcCtD
Flutamide—Laboratory test abnormal—Doxorubicin—uterine cancer	0.000787	0.0057	CcSEcCtD
Flutamide—CYP1B1—female reproductive system—uterine cancer	0.000784	0.0142	CbGeAlD
Flutamide—CYP1A1—epithelium—uterine cancer	0.000747	0.0135	CbGeAlD
Flutamide—AR—female reproductive system—uterine cancer	0.000743	0.0134	CbGeAlD
Flutamide—CYP1A1—uterine cervix—uterine cancer	0.00074	0.0134	CbGeAlD
Flutamide—CYP3A5—uterine cervix—uterine cancer	0.000724	0.0131	CbGeAlD
Flutamide—CYP1B1—female gonad—uterine cancer	0.000714	0.0129	CbGeAlD
Flutamide—CYP1A2—renal system—uterine cancer	0.000702	0.0127	CbGeAlD
Flutamide—Hyperglycaemia—Progesterone—uterine cancer	0.000701	0.00508	CcSEcCtD
Flutamide—Drowsiness—Progesterone—uterine cancer	0.000693	0.00502	CcSEcCtD
Flutamide—CYP1A1—renal system—uterine cancer	0.000692	0.0125	CbGeAlD
Flutamide—CYP3A5—renal system—uterine cancer	0.000677	0.0123	CbGeAlD
Flutamide—AR—female gonad—uterine cancer	0.000676	0.0122	CbGeAlD
Flutamide—Jaundice—Progesterone—uterine cancer	0.000676	0.00489	CcSEcCtD
Flutamide—AR—vagina—uterine cancer	0.000672	0.0122	CbGeAlD
Flutamide—Ulcer—Etoposide—uterine cancer	0.00067	0.00485	CcSEcCtD
Flutamide—CYP1A1—mammalian vulva—uterine cancer	0.000648	0.0117	CbGeAlD
Flutamide—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.000636	0.0046	CcSEcCtD
Flutamide—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.000628	0.00455	CcSEcCtD
Flutamide—CYP2C19—vagina—uterine cancer	0.000623	0.0113	CbGeAlD
Flutamide—Hepatitis—Progesterone—uterine cancer	0.000622	0.00451	CcSEcCtD
Flutamide—CYP1A1—uterus—uterine cancer	0.000617	0.0112	CbGeAlD
Flutamide—Oedema peripheral—Progesterone—uterine cancer	0.000613	0.00444	CcSEcCtD
Flutamide—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.000612	0.00443	CcSEcCtD
Flutamide—Transaminases increased—Epirubicin—uterine cancer	0.000584	0.00423	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Dactinomycin—uterine cancer	0.000573	0.00415	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.000573	0.00415	CcSEcCtD
Flutamide—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.000564	0.00408	CcSEcCtD
Flutamide—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.000556	0.00402	CcSEcCtD
Flutamide—CYP1A1—female reproductive system—uterine cancer	0.000555	0.01	CbGeAlD
Flutamide—Erythema—Progesterone—uterine cancer	0.000542	0.00392	CcSEcCtD
Flutamide—Transaminases increased—Doxorubicin—uterine cancer	0.000541	0.00391	CcSEcCtD
Flutamide—Tension—Progesterone—uterine cancer	0.000532	0.00385	CcSEcCtD
Flutamide—Nervousness—Progesterone—uterine cancer	0.000526	0.00381	CcSEcCtD
Flutamide—CYP3A4—renal system—uterine cancer	0.000508	0.0092	CbGeAlD
Flutamide—CYP1A1—female gonad—uterine cancer	0.000505	0.00914	CbGeAlD
Flutamide—Ill-defined disorder—Progesterone—uterine cancer	0.000503	0.00364	CcSEcCtD
Flutamide—CYP1A1—vagina—uterine cancer	0.000502	0.00908	CbGeAlD
Flutamide—Anaemia—Progesterone—uterine cancer	0.000501	0.00363	CcSEcCtD
Flutamide—CYP3A5—female gonad—uterine cancer	0.000493	0.00893	CbGeAlD
Flutamide—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.000491	0.00355	CcSEcCtD
Flutamide—CYP3A5—vagina—uterine cancer	0.00049	0.00888	CbGeAlD
Flutamide—Malaise—Progesterone—uterine cancer	0.000489	0.00354	CcSEcCtD
Flutamide—Tension—Medroxyprogesterone Acetate—uterine cancer	0.000482	0.00349	CcSEcCtD
Flutamide—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.000477	0.00345	CcSEcCtD
Flutamide—Herpes zoster—Epirubicin—uterine cancer	0.000472	0.00342	CcSEcCtD
Flutamide—Hypertension—Progesterone—uterine cancer	0.000468	0.00339	CcSEcCtD
Flutamide—Anxiety—Progesterone—uterine cancer	0.00046	0.00333	CcSEcCtD
Flutamide—CYP1B1—lymph node—uterine cancer	0.000459	0.00831	CbGeAlD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.000458	0.00332	CcSEcCtD
Flutamide—Discomfort—Progesterone—uterine cancer	0.000456	0.0033	CcSEcCtD
Flutamide—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000456	0.0033	CcSEcCtD
Flutamide—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000454	0.00328	CcSEcCtD
Flutamide—Confusional state—Progesterone—uterine cancer	0.000446	0.00323	CcSEcCtD
Flutamide—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000443	0.00321	CcSEcCtD
Flutamide—Oedema—Progesterone—uterine cancer	0.000442	0.0032	CcSEcCtD
Flutamide—Hepatitis—Dactinomycin—uterine cancer	0.00044	0.00318	CcSEcCtD
Flutamide—Herpes zoster—Doxorubicin—uterine cancer	0.000437	0.00316	CcSEcCtD
Flutamide—AR—lymph node—uterine cancer	0.000435	0.00787	CbGeAlD
Flutamide—Skin disorder—Progesterone—uterine cancer	0.000429	0.00311	CcSEcCtD
Flutamide—Liver injury—Epirubicin—uterine cancer	0.000422	0.00306	CcSEcCtD
Flutamide—Anorexia—Progesterone—uterine cancer	0.000421	0.00305	CcSEcCtD
Flutamide—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000417	0.00302	CcSEcCtD
Flutamide—Neoplasm malignant—Epirubicin—uterine cancer	0.000416	0.00301	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000415	0.003	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.000414	0.003	CcSEcCtD
Flutamide—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000413	0.00299	CcSEcCtD
Flutamide—CYP3A4—female reproductive system—uterine cancer	0.000407	0.00737	CbGeAlD
Flutamide—Jaundice cholestatic—Epirubicin—uterine cancer	0.000404	0.00293	CcSEcCtD
Flutamide—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000404	0.00292	CcSEcCtD
Flutamide—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000401	0.0029	CcSEcCtD
Flutamide—Insomnia—Progesterone—uterine cancer	0.0004	0.0029	CcSEcCtD
Flutamide—Rectal haemorrhage—Epirubicin—uterine cancer	0.000393	0.00285	CcSEcCtD
Flutamide—Somnolence—Progesterone—uterine cancer	0.000393	0.00285	CcSEcCtD
Flutamide—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000392	0.00284	CcSEcCtD
Flutamide—Liver injury—Doxorubicin—uterine cancer	0.000391	0.00283	CcSEcCtD
Flutamide—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000389	0.00282	CcSEcCtD
Flutamide—Neoplasm malignant—Doxorubicin—uterine cancer	0.000385	0.00279	CcSEcCtD
Flutamide—Decreased appetite—Progesterone—uterine cancer	0.000384	0.00278	CcSEcCtD
Flutamide—Erythema—Dactinomycin—uterine cancer	0.000383	0.00277	CcSEcCtD
Flutamide—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000382	0.00276	CcSEcCtD
Flutamide—Fatigue—Progesterone—uterine cancer	0.000381	0.00276	CcSEcCtD
Flutamide—Constipation—Progesterone—uterine cancer	0.000378	0.00274	CcSEcCtD
Flutamide—Ulcer—Epirubicin—uterine cancer	0.000376	0.00272	CcSEcCtD
Flutamide—Jaundice cholestatic—Doxorubicin—uterine cancer	0.000374	0.00271	CcSEcCtD
Flutamide—Feeling abnormal—Progesterone—uterine cancer	0.000364	0.00264	CcSEcCtD
Flutamide—Rectal haemorrhage—Doxorubicin—uterine cancer	0.000364	0.00264	CcSEcCtD
Flutamide—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000362	0.00262	CcSEcCtD
Flutamide—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000356	0.00258	CcSEcCtD
Flutamide—Pulmonary embolism—Epirubicin—uterine cancer	0.000355	0.00257	CcSEcCtD
Flutamide—Ill-defined disorder—Dactinomycin—uterine cancer	0.000355	0.00257	CcSEcCtD
Flutamide—Anaemia—Dactinomycin—uterine cancer	0.000354	0.00256	CcSEcCtD
Flutamide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000348	0.00252	CcSEcCtD
Flutamide—Ulcer—Doxorubicin—uterine cancer	0.000348	0.00252	CcSEcCtD
Flutamide—Cystitis noninfective—Epirubicin—uterine cancer	0.000347	0.00251	CcSEcCtD
Flutamide—Jaundice—Etoposide—uterine cancer	0.000346	0.0025	CcSEcCtD
Flutamide—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000345	0.0025	CcSEcCtD
Flutamide—Malaise—Dactinomycin—uterine cancer	0.000345	0.0025	CcSEcCtD
Flutamide—Cystitis—Epirubicin—uterine cancer	0.000343	0.00248	CcSEcCtD
Flutamide—Leukopenia—Dactinomycin—uterine cancer	0.000343	0.00248	CcSEcCtD
Flutamide—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000343	0.00248	CcSEcCtD
Flutamide—Blood urea increased—Epirubicin—uterine cancer	0.000336	0.00243	CcSEcCtD
Flutamide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00033	0.00239	CcSEcCtD
Flutamide—Pulmonary embolism—Doxorubicin—uterine cancer	0.000329	0.00238	CcSEcCtD
Flutamide—CYP1A1—lymph node—uterine cancer	0.000324	0.00587	CbGeAlD
Flutamide—Discomfort—Dactinomycin—uterine cancer	0.000322	0.00233	CcSEcCtD
Flutamide—Neoplasm—Epirubicin—uterine cancer	0.000321	0.00233	CcSEcCtD
Flutamide—Ecchymosis—Epirubicin—uterine cancer	0.000321	0.00233	CcSEcCtD
Flutamide—Bladder pain—Epirubicin—uterine cancer	0.000321	0.00233	CcSEcCtD
Flutamide—Cystitis noninfective—Doxorubicin—uterine cancer	0.000321	0.00233	CcSEcCtD
Flutamide—Cystitis—Doxorubicin—uterine cancer	0.000318	0.0023	CcSEcCtD
Flutamide—Asthenia—Progesterone—uterine cancer	0.000317	0.0023	CcSEcCtD
Flutamide—Pruritus—Progesterone—uterine cancer	0.000313	0.00226	CcSEcCtD
Flutamide—Oedema—Dactinomycin—uterine cancer	0.000313	0.00226	CcSEcCtD
Flutamide—Blood urea increased—Doxorubicin—uterine cancer	0.00031	0.00225	CcSEcCtD
Flutamide—Thrombocytopenia—Dactinomycin—uterine cancer	0.000306	0.00222	CcSEcCtD
Flutamide—Diarrhoea—Progesterone—uterine cancer	0.000303	0.00219	CcSEcCtD
Flutamide—Anorexia—Dactinomycin—uterine cancer	0.000298	0.00216	CcSEcCtD
Flutamide—Ecchymosis—Doxorubicin—uterine cancer	0.000297	0.00215	CcSEcCtD
Flutamide—Neoplasm—Doxorubicin—uterine cancer	0.000297	0.00215	CcSEcCtD
Flutamide—Bladder pain—Doxorubicin—uterine cancer	0.000297	0.00215	CcSEcCtD
Flutamide—Diabetes mellitus—Epirubicin—uterine cancer	0.000297	0.00215	CcSEcCtD
Flutamide—Dizziness—Progesterone—uterine cancer	0.000292	0.00212	CcSEcCtD
Flutamide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000287	0.00208	CcSEcCtD
Flutamide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000283	0.00205	CcSEcCtD
Flutamide—Vomiting—Progesterone—uterine cancer	0.000281	0.00204	CcSEcCtD
Flutamide—Rash—Progesterone—uterine cancer	0.000279	0.00202	CcSEcCtD
Flutamide—Dermatitis—Progesterone—uterine cancer	0.000279	0.00202	CcSEcCtD
Flutamide—Headache—Progesterone—uterine cancer	0.000277	0.00201	CcSEcCtD
Flutamide—Hot flush—Epirubicin—uterine cancer	0.000276	0.002	CcSEcCtD
Flutamide—Increased appetite—Epirubicin—uterine cancer	0.000275	0.00199	CcSEcCtD
Flutamide—Diabetes mellitus—Doxorubicin—uterine cancer	0.000274	0.00199	CcSEcCtD
Flutamide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000274	0.00198	CcSEcCtD
Flutamide—Menopausal symptoms—Epirubicin—uterine cancer	0.000273	0.00198	CcSEcCtD
Flutamide—Decreased appetite—Dactinomycin—uterine cancer	0.000272	0.00197	CcSEcCtD
Flutamide—Dermatitis bullous—Epirubicin—uterine cancer	0.00027	0.00195	CcSEcCtD
Flutamide—Fatigue—Dactinomycin—uterine cancer	0.000269	0.00195	CcSEcCtD
Flutamide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000265	0.00192	CcSEcCtD
Flutamide—Nausea—Progesterone—uterine cancer	0.000263	0.0019	CcSEcCtD
Flutamide—Feeling abnormal—Dactinomycin—uterine cancer	0.000258	0.00186	CcSEcCtD
Flutamide—Ill-defined disorder—Etoposide—uterine cancer	0.000257	0.00186	CcSEcCtD
Flutamide—Anaemia—Etoposide—uterine cancer	0.000256	0.00185	CcSEcCtD
Flutamide—Hot flush—Doxorubicin—uterine cancer	0.000255	0.00185	CcSEcCtD
Flutamide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000255	0.00184	CcSEcCtD
Flutamide—Increased appetite—Doxorubicin—uterine cancer	0.000254	0.00184	CcSEcCtD
Flutamide—Menopausal symptoms—Doxorubicin—uterine cancer	0.000253	0.00183	CcSEcCtD
Flutamide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000253	0.00183	CcSEcCtD
Flutamide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000252	0.00183	CcSEcCtD
Flutamide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000251	0.00182	CcSEcCtD
Flutamide—Malaise—Etoposide—uterine cancer	0.00025	0.00181	CcSEcCtD
Flutamide—Dermatitis bullous—Doxorubicin—uterine cancer	0.00025	0.00181	CcSEcCtD
Flutamide—Leukopenia—Etoposide—uterine cancer	0.000248	0.0018	CcSEcCtD
Flutamide—Hypertension—Etoposide—uterine cancer	0.000239	0.00173	CcSEcCtD
Flutamide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000238	0.00172	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000234	0.0017	CcSEcCtD
Flutamide—Discomfort—Etoposide—uterine cancer	0.000233	0.00169	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000232	0.00168	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000232	0.00168	CcSEcCtD
Flutamide—Confusional state—Etoposide—uterine cancer	0.000228	0.00165	CcSEcCtD
Flutamide—Asthenia—Dactinomycin—uterine cancer	0.000224	0.00162	CcSEcCtD
Flutamide—Thrombocytopenia—Etoposide—uterine cancer	0.000221	0.0016	CcSEcCtD
Flutamide—Skin disorder—Etoposide—uterine cancer	0.00022	0.00159	CcSEcCtD
Flutamide—Anorexia—Etoposide—uterine cancer	0.000216	0.00156	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000215	0.00156	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000215	0.00156	CcSEcCtD
Flutamide—Diarrhoea—Dactinomycin—uterine cancer	0.000214	0.00155	CcSEcCtD
Flutamide—Photosensitivity reaction—Epirubicin—uterine cancer	0.000204	0.00147	CcSEcCtD
Flutamide—Hyperglycaemia—Epirubicin—uterine cancer	0.000201	0.00146	CcSEcCtD
Flutamide—Somnolence—Etoposide—uterine cancer	0.000201	0.00146	CcSEcCtD
Flutamide—Drowsiness—Epirubicin—uterine cancer	0.000199	0.00144	CcSEcCtD
Flutamide—Vomiting—Dactinomycin—uterine cancer	0.000199	0.00144	CcSEcCtD
Flutamide—Rash—Dactinomycin—uterine cancer	0.000197	0.00143	CcSEcCtD
Flutamide—Decreased appetite—Etoposide—uterine cancer	0.000197	0.00142	CcSEcCtD
Flutamide—Fatigue—Etoposide—uterine cancer	0.000195	0.00141	CcSEcCtD
Flutamide—Jaundice—Epirubicin—uterine cancer	0.000194	0.0014	CcSEcCtD
Flutamide—Constipation—Etoposide—uterine cancer	0.000193	0.0014	CcSEcCtD
Flutamide—Haematuria—Epirubicin—uterine cancer	0.00019	0.00137	CcSEcCtD
Flutamide—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000188	0.00136	CcSEcCtD
Flutamide—Feeling abnormal—Etoposide—uterine cancer	0.000186	0.00135	CcSEcCtD
Flutamide—Hyperglycaemia—Doxorubicin—uterine cancer	0.000186	0.00135	CcSEcCtD
Flutamide—Nausea—Dactinomycin—uterine cancer	0.000186	0.00134	CcSEcCtD
Flutamide—Drowsiness—Doxorubicin—uterine cancer	0.000184	0.00133	CcSEcCtD
Flutamide—Jaundice—Doxorubicin—uterine cancer	0.000179	0.0013	CcSEcCtD
Flutamide—Hepatitis—Epirubicin—uterine cancer	0.000178	0.00129	CcSEcCtD
Flutamide—Oedema peripheral—Epirubicin—uterine cancer	0.000176	0.00127	CcSEcCtD
Flutamide—Haematuria—Doxorubicin—uterine cancer	0.000175	0.00127	CcSEcCtD
Flutamide—Hepatitis—Doxorubicin—uterine cancer	0.000165	0.0012	CcSEcCtD
Flutamide—Oedema peripheral—Doxorubicin—uterine cancer	0.000163	0.00118	CcSEcCtD
Flutamide—Asthenia—Etoposide—uterine cancer	0.000162	0.00117	CcSEcCtD
Flutamide—Pruritus—Etoposide—uterine cancer	0.00016	0.00116	CcSEcCtD
Flutamide—Erythema—Epirubicin—uterine cancer	0.000155	0.00112	CcSEcCtD
Flutamide—Diarrhoea—Etoposide—uterine cancer	0.000155	0.00112	CcSEcCtD
Flutamide—Tension—Epirubicin—uterine cancer	0.000152	0.0011	CcSEcCtD
Flutamide—Nervousness—Epirubicin—uterine cancer	0.000151	0.00109	CcSEcCtD
Flutamide—Dizziness—Etoposide—uterine cancer	0.00015	0.00108	CcSEcCtD
Flutamide—Ill-defined disorder—Epirubicin—uterine cancer	0.000144	0.00104	CcSEcCtD
Flutamide—Vomiting—Etoposide—uterine cancer	0.000144	0.00104	CcSEcCtD
Flutamide—Erythema—Doxorubicin—uterine cancer	0.000144	0.00104	CcSEcCtD
Flutamide—Anaemia—Epirubicin—uterine cancer	0.000144	0.00104	CcSEcCtD
Flutamide—Rash—Etoposide—uterine cancer	0.000143	0.00103	CcSEcCtD
Flutamide—Dermatitis—Etoposide—uterine cancer	0.000142	0.00103	CcSEcCtD
Flutamide—Headache—Etoposide—uterine cancer	0.000142	0.00103	CcSEcCtD
Flutamide—Tension—Doxorubicin—uterine cancer	0.000141	0.00102	CcSEcCtD
Flutamide—Malaise—Epirubicin—uterine cancer	0.00014	0.00101	CcSEcCtD
Flutamide—Nervousness—Doxorubicin—uterine cancer	0.00014	0.00101	CcSEcCtD
Flutamide—Leukopenia—Epirubicin—uterine cancer	0.000139	0.00101	CcSEcCtD
Flutamide—Nausea—Etoposide—uterine cancer	0.000134	0.000973	CcSEcCtD
Flutamide—Hypertension—Epirubicin—uterine cancer	0.000134	0.000971	CcSEcCtD
Flutamide—Ill-defined disorder—Doxorubicin—uterine cancer	0.000133	0.000966	CcSEcCtD
Flutamide—Anaemia—Doxorubicin—uterine cancer	0.000133	0.000962	CcSEcCtD
Flutamide—Anxiety—Epirubicin—uterine cancer	0.000132	0.000954	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000131	0.000951	CcSEcCtD
Flutamide—Discomfort—Epirubicin—uterine cancer	0.000131	0.000946	CcSEcCtD
Flutamide—Malaise—Doxorubicin—uterine cancer	0.00013	0.000938	CcSEcCtD
Flutamide—Leukopenia—Doxorubicin—uterine cancer	0.000129	0.000932	CcSEcCtD
Flutamide—Confusional state—Epirubicin—uterine cancer	0.000128	0.000926	CcSEcCtD
Flutamide—Oedema—Epirubicin—uterine cancer	0.000127	0.000918	CcSEcCtD
Flutamide—Thrombocytopenia—Epirubicin—uterine cancer	0.000124	0.000899	CcSEcCtD
Flutamide—Hypertension—Doxorubicin—uterine cancer	0.000124	0.000898	CcSEcCtD
Flutamide—Skin disorder—Epirubicin—uterine cancer	0.000123	0.000892	CcSEcCtD
Flutamide—Anxiety—Doxorubicin—uterine cancer	0.000122	0.000883	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000122	0.00088	CcSEcCtD
Flutamide—Discomfort—Doxorubicin—uterine cancer	0.000121	0.000875	CcSEcCtD
Flutamide—Anorexia—Epirubicin—uterine cancer	0.000121	0.000875	CcSEcCtD
Flutamide—AHR—Circadian rythm related genes—TP53—uterine cancer	0.000119	0.00172	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—ESR1—uterine cancer	0.000118	0.00172	CbGpPWpGaD
Flutamide—Confusional state—Doxorubicin—uterine cancer	0.000118	0.000856	CcSEcCtD
Flutamide—CYP1A1—Metapathway biotransformation—GPX3—uterine cancer	0.000118	0.00171	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—uterine cancer	0.000118	0.0017	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—CYP11A1—uterine cancer	0.000117	0.0017	CbGpPWpGaD
Flutamide—Oedema—Doxorubicin—uterine cancer	0.000117	0.000849	CcSEcCtD
Flutamide—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	0.000116	0.00169	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	0.000116	0.00169	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—CTNNB1—uterine cancer	0.000116	0.00168	CbGpPWpGaD
Flutamide—CYP3A5—Metapathway biotransformation—CYP11A1—uterine cancer	0.000116	0.00168	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000116	0.00167	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000116	0.00167	CbGpPWpGaD
Flutamide—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000115	0.00167	CbGpPWpGaD
Flutamide—Thrombocytopenia—Doxorubicin—uterine cancer	0.000115	0.000832	CcSEcCtD
Flutamide—Insomnia—Epirubicin—uterine cancer	0.000115	0.00083	CcSEcCtD
Flutamide—Skin disorder—Doxorubicin—uterine cancer	0.000114	0.000825	CcSEcCtD
Flutamide—AR—Androgen receptor signaling pathway—PTEN—uterine cancer	0.000113	0.00164	CbGpPWpGaD
Flutamide—Somnolence—Epirubicin—uterine cancer	0.000113	0.000816	CcSEcCtD
Flutamide—Anorexia—Doxorubicin—uterine cancer	0.000112	0.00081	CcSEcCtD
Flutamide—CYP1A1—Biological oxidations—CYP11A1—uterine cancer	0.000111	0.00161	CbGpPWpGaD
Flutamide—Decreased appetite—Epirubicin—uterine cancer	0.00011	0.000798	CcSEcCtD
Flutamide—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	0.00011	0.00159	CbGpPWpGaD
Flutamide—CYP1A1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000109	0.00158	CbGpPWpGaD
Flutamide—Fatigue—Epirubicin—uterine cancer	0.000109	0.000791	CcSEcCtD
Flutamide—CYP3A5—Metapathway biotransformation—AKR1C3—uterine cancer	0.000109	0.00158	CbGpPWpGaD
Flutamide—Constipation—Epirubicin—uterine cancer	0.000108	0.000785	CcSEcCtD
Flutamide—AR—Androgen receptor signaling pathway—EP300—uterine cancer	0.000108	0.00156	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	0.000106	0.00154	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	0.000106	0.00154	CbGpPWpGaD
Flutamide—Insomnia—Doxorubicin—uterine cancer	0.000106	0.000768	CcSEcCtD
Flutamide—AR—Gene Expression—CHD4—uterine cancer	0.000105	0.00153	CbGpPWpGaD
Flutamide—Feeling abnormal—Epirubicin—uterine cancer	0.000104	0.000756	CcSEcCtD
Flutamide—Somnolence—Doxorubicin—uterine cancer	0.000104	0.000755	CcSEcCtD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	0.000104	0.0015	CbGpPWpGaD
Flutamide—CYP1A1—Metapathway biotransformation—AKR1C3—uterine cancer	0.000103	0.0015	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CDH1—uterine cancer	0.000103	0.00149	CbGpPWpGaD
Flutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000103	0.00149	CbGpPWpGaD
Flutamide—Decreased appetite—Doxorubicin—uterine cancer	0.000102	0.000738	CcSEcCtD
Flutamide—Fatigue—Doxorubicin—uterine cancer	0.000101	0.000732	CcSEcCtD
Flutamide—Constipation—Doxorubicin—uterine cancer	0.0001	0.000726	CcSEcCtD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	9.97e-05	0.00145	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	9.84e-05	0.00143	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	9.82e-05	0.00142	CbGpPWpGaD
Flutamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	9.79e-05	0.00142	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	9.67e-05	0.0014	CbGpPWpGaD
Flutamide—Feeling abnormal—Doxorubicin—uterine cancer	9.67e-05	0.0007	CcSEcCtD
Flutamide—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	9.63e-05	0.0014	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—EP300—uterine cancer	9.34e-05	0.00135	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	9.34e-05	0.00135	CbGpPWpGaD
Flutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	9.32e-05	0.00135	CbGpPWpGaD
Flutamide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	9.2e-05	0.00133	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—PGR—uterine cancer	9.13e-05	0.00132	CbGpPWpGaD
Flutamide—Asthenia—Epirubicin—uterine cancer	9.1e-05	0.000659	CcSEcCtD
Flutamide—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	9.07e-05	0.00131	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	8.99e-05	0.0013	CbGpPWpGaD
Flutamide—Pruritus—Epirubicin—uterine cancer	8.97e-05	0.000649	CcSEcCtD
Flutamide—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	8.95e-05	0.0013	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	8.84e-05	0.00128	CbGpPWpGaD
Flutamide—AR—Gene Expression—SUZ12—uterine cancer	8.83e-05	0.00128	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—AKT1—uterine cancer	8.82e-05	0.00128	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	8.74e-05	0.00127	CbGpPWpGaD
Flutamide—Diarrhoea—Epirubicin—uterine cancer	8.68e-05	0.000628	CcSEcCtD
Flutamide—CYP3A5—Biological oxidations—CYP19A1—uterine cancer	8.63e-05	0.00125	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	8.55e-05	0.00124	CbGpPWpGaD
Flutamide—CYP3A5—Metapathway biotransformation—CYP19A1—uterine cancer	8.51e-05	0.00123	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	8.48e-05	0.00123	CbGpPWpGaD
Flutamide—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	8.45e-05	0.00122	CbGpPWpGaD
Flutamide—Asthenia—Doxorubicin—uterine cancer	8.42e-05	0.000609	CcSEcCtD
Flutamide—Dizziness—Epirubicin—uterine cancer	8.38e-05	0.000607	CcSEcCtD
Flutamide—Pruritus—Doxorubicin—uterine cancer	8.3e-05	0.000601	CcSEcCtD
Flutamide—CYP1A1—Biological oxidations—CYP19A1—uterine cancer	8.15e-05	0.00118	CbGpPWpGaD
Flutamide—Vomiting—Epirubicin—uterine cancer	8.06e-05	0.000584	CcSEcCtD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	8.05e-05	0.00117	CbGpPWpGaD
Flutamide—CYP1A1—Metapathway biotransformation—CYP19A1—uterine cancer	8.04e-05	0.00117	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—ESR2—uterine cancer	8.04e-05	0.00117	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—CXCL8—uterine cancer	8.03e-05	0.00116	CbGpPWpGaD
Flutamide—Diarrhoea—Doxorubicin—uterine cancer	8.03e-05	0.000581	CcSEcCtD
Flutamide—Rash—Epirubicin—uterine cancer	7.99e-05	0.000579	CcSEcCtD
Flutamide—Dermatitis—Epirubicin—uterine cancer	7.99e-05	0.000578	CcSEcCtD
Flutamide—Headache—Epirubicin—uterine cancer	7.94e-05	0.000575	CcSEcCtD
Flutamide—Dizziness—Doxorubicin—uterine cancer	7.76e-05	0.000562	CcSEcCtD
Flutamide—AR—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	7.61e-05	0.0011	CbGpPWpGaD
Flutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	7.55e-05	0.0011	CbGpPWpGaD
Flutamide—Nausea—Epirubicin—uterine cancer	7.53e-05	0.000545	CcSEcCtD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	7.52e-05	0.00109	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	7.51e-05	0.00109	CbGpPWpGaD
Flutamide—Vomiting—Doxorubicin—uterine cancer	7.46e-05	0.00054	CcSEcCtD
Flutamide—AR—Integrated Breast Cancer Pathway—PTEN—uterine cancer	7.41e-05	0.00107	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	7.41e-05	0.00107	CbGpPWpGaD
Flutamide—Rash—Doxorubicin—uterine cancer	7.4e-05	0.000536	CcSEcCtD
Flutamide—Dermatitis—Doxorubicin—uterine cancer	7.39e-05	0.000535	CcSEcCtD
Flutamide—Headache—Doxorubicin—uterine cancer	7.35e-05	0.000532	CcSEcCtD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	7.2e-05	0.00104	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—SRD5A2—uterine cancer	7.12e-05	0.00103	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—NDUFB11—uterine cancer	7.12e-05	0.00103	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	7.11e-05	0.00103	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	7.11e-05	0.00103	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—EP300—uterine cancer	7.07e-05	0.00102	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	7.07e-05	0.00102	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	7.03e-05	0.00102	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	6.97e-05	0.00101	CbGpPWpGaD
Flutamide—Nausea—Doxorubicin—uterine cancer	6.97e-05	0.000504	CcSEcCtD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.91e-05	0.001	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—EP300—uterine cancer	6.89e-05	0.000999	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	6.78e-05	0.000983	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	6.78e-05	0.000983	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	6.7e-05	0.000971	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	6.67e-05	0.000967	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	6.67e-05	0.000967	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	6.6e-05	0.000957	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	6.58e-05	0.000954	CbGpPWpGaD
Flutamide—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	6.58e-05	0.000954	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—CDKN2B—uterine cancer	6.54e-05	0.000949	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.53e-05	0.000946	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—VEGFA—uterine cancer	6.52e-05	0.000946	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—AKT1—uterine cancer	6.52e-05	0.000945	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	6.39e-05	0.000926	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	6.3e-05	0.000914	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	6.27e-05	0.000909	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	6.14e-05	0.000891	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—SMAD3—uterine cancer	5.97e-05	0.000866	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	5.95e-05	0.000863	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	5.95e-05	0.000863	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	5.86e-05	0.000849	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.82e-05	0.000844	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.82e-05	0.000844	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	5.79e-05	0.00084	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—KRAS—uterine cancer	5.69e-05	0.000825	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	5.64e-05	0.000817	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	5.57e-05	0.000807	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	5.55e-05	0.000804	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	5.45e-05	0.000791	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	5.38e-05	0.00078	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.22e-05	0.000757	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	5.2e-05	0.000754	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—AKR1B1—uterine cancer	5.14e-05	0.000746	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—STAR—uterine cancer	5.14e-05	0.000746	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	5.13e-05	0.000743	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.08e-05	0.000737	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	5.08e-05	0.000736	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—TP53—uterine cancer	5.06e-05	0.000733	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—ESR1—uterine cancer	4.88e-05	0.000707	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	4.79e-05	0.000695	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	4.72e-05	0.000684	CbGpPWpGaD
Flutamide—CYP1A1—PPARA activates gene expression—EP300—uterine cancer	4.65e-05	0.000674	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—SRD5A2—uterine cancer	4.64e-05	0.000672	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NDUFB11—uterine cancer	4.64e-05	0.000672	CbGpPWpGaD
Flutamide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	4.55e-05	0.00066	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.54e-05	0.000657	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.54e-05	0.000657	CbGpPWpGaD
Flutamide—AR—Gene Expression—PGR—uterine cancer	4.4e-05	0.000637	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NDUFB11—uterine cancer	4.38e-05	0.000635	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SRD5A2—uterine cancer	4.38e-05	0.000635	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	4.33e-05	0.000628	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—AKT1—uterine cancer	4.27e-05	0.000619	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.27e-05	0.000619	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.26e-05	0.000617	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	4.19e-05	0.000608	CbGpPWpGaD
Flutamide—AR—Gene Expression—EZH2—uterine cancer	4.18e-05	0.000605	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	4.07e-05	0.000591	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—POLD1—uterine cancer	4.04e-05	0.000585	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.02e-05	0.000583	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	4.01e-05	0.000582	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	3.96e-05	0.000574	CbGpPWpGaD
Flutamide—AR—Gene Expression—ESR2—uterine cancer	3.87e-05	0.000561	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—AKR1C1—uterine cancer	3.78e-05	0.000547	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NDUFB11—uterine cancer	3.59e-05	0.00052	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SRD5A2—uterine cancer	3.59e-05	0.00052	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.54e-05	0.000513	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.48e-05	0.000505	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—RRM2—uterine cancer	3.37e-05	0.000488	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—AKR1B1—uterine cancer	3.35e-05	0.000486	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—STAR—uterine cancer	3.35e-05	0.000486	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.33e-05	0.000483	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.29e-05	0.000477	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—DCN—uterine cancer	3.27e-05	0.000474	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—STAR—uterine cancer	3.17e-05	0.000459	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—AKR1B1—uterine cancer	3.17e-05	0.000459	CbGpPWpGaD
Flutamide—AR—Gene Expression—CDKN2B—uterine cancer	3.15e-05	0.000457	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	3.14e-05	0.000454	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.13e-05	0.000454	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP11A1—uterine cancer	3.08e-05	0.000446	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—AKR1C3—uterine cancer	2.91e-05	0.000421	CbGpPWpGaD
Flutamide—AR—Gene Expression—SMAD3—uterine cancer	2.88e-05	0.000417	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NDUFB11—uterine cancer	2.79e-05	0.000405	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SRD5A2—uterine cancer	2.79e-05	0.000405	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.71e-05	0.000393	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—POLD1—uterine cancer	2.63e-05	0.000381	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—AKR1B1—uterine cancer	2.59e-05	0.000376	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—STAR—uterine cancer	2.59e-05	0.000376	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.56e-05	0.000372	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.56e-05	0.000371	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—POLD1—uterine cancer	2.49e-05	0.00036	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—AKR1C1—uterine cancer	2.46e-05	0.000357	CbGpPWpGaD
Flutamide—AR—Gene Expression—ESR1—uterine cancer	2.35e-05	0.00034	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—AKR1C1—uterine cancer	2.33e-05	0.000337	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP19A1—uterine cancer	2.26e-05	0.000328	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—STK11—uterine cancer	2.26e-05	0.000328	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—RRM2—uterine cancer	2.19e-05	0.000318	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.16e-05	0.000313	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.16e-05	0.000313	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—DCN—uterine cancer	2.13e-05	0.000309	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.13e-05	0.000308	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—RRM2—uterine cancer	2.07e-05	0.0003	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—POLD1—uterine cancer	2.03e-05	0.000295	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.03e-05	0.000294	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—STAR—uterine cancer	2.02e-05	0.000293	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AKR1B1—uterine cancer	2.02e-05	0.000293	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—DCN—uterine cancer	2.01e-05	0.000292	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP11A1—uterine cancer	2.01e-05	0.000291	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2e-05	0.000289	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.9e-05	0.000276	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP11A1—uterine cancer	1.9e-05	0.000275	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—AKR1C3—uterine cancer	1.89e-05	0.000275	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—AKR1C3—uterine cancer	1.79e-05	0.000259	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—MTHFR—uterine cancer	1.7e-05	0.000247	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—RRM2—uterine cancer	1.7e-05	0.000246	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—DCN—uterine cancer	1.65e-05	0.000239	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—POLD1—uterine cancer	1.59e-05	0.00023	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—STAR—uterine cancer	1.56e-05	0.000226	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.56e-05	0.000226	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.55e-05	0.000225	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.5e-05	0.000217	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.48e-05	0.000215	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—STK11—uterine cancer	1.48e-05	0.000214	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.48e-05	0.000214	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.46e-05	0.000212	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—STK11—uterine cancer	1.39e-05	0.000202	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP19A1—uterine cancer	1.39e-05	0.000202	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—RRM2—uterine cancer	1.32e-05	0.000192	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.31e-05	0.00019	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—DCN—uterine cancer	1.28e-05	0.000186	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.25e-05	0.000181	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—POLD1—uterine cancer	1.22e-05	0.000177	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.21e-05	0.000175	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.14e-05	0.000166	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.14e-05	0.000165	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP19A1—uterine cancer	1.14e-05	0.000165	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—STK11—uterine cancer	1.14e-05	0.000165	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—MTHFR—uterine cancer	1.11e-05	0.000161	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.07e-05	0.000155	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—MTHFR—uterine cancer	1.05e-05	0.000152	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.02e-05	0.000148	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—RRM2—uterine cancer	1.02e-05	0.000148	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—DCN—uterine cancer	9.9e-06	0.000144	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTEN—uterine cancer	9.47e-06	0.000137	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP11A1—uterine cancer	9.33e-06	0.000135	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.24e-06	0.000134	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—EP300—uterine cancer	9.03e-06	0.000131	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP19A1—uterine cancer	8.89e-06	0.000129	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—STK11—uterine cancer	8.89e-06	0.000129	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AKR1C3—uterine cancer	8.81e-06	0.000128	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—MTHFR—uterine cancer	8.58e-06	0.000124	CbGpPWpGaD
Flutamide—AR—Gene Expression—AKT1—uterine cancer	8.47e-06	0.000123	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.35e-06	0.000121	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.96e-06	0.000115	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.56e-06	0.00011	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP19A1—uterine cancer	6.86e-06	9.95e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—STK11—uterine cancer	6.86e-06	9.95e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—MTHFR—uterine cancer	6.68e-06	9.69e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CA—uterine cancer	6.68e-06	9.68e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTEN—uterine cancer	6.17e-06	8.94e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.89e-06	8.54e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—EP300—uterine cancer	5.89e-06	8.53e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTEN—uterine cancer	5.83e-06	8.45e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—EP300—uterine cancer	5.56e-06	8.06e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—AKT1—uterine cancer	5.46e-06	7.91e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—MTHFR—uterine cancer	5.16e-06	7.48e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTEN—uterine cancer	4.77e-06	6.92e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—EP300—uterine cancer	4.55e-06	6.6e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CA—uterine cancer	4.35e-06	6.31e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CA—uterine cancer	4.11e-06	5.96e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTEN—uterine cancer	3.72e-06	5.39e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—AKT1—uterine cancer	3.56e-06	5.16e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—EP300—uterine cancer	3.55e-06	5.14e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CA—uterine cancer	3.37e-06	4.88e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—AKT1—uterine cancer	3.36e-06	4.87e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTEN—uterine cancer	2.87e-06	4.16e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—AKT1—uterine cancer	2.75e-06	3.99e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—EP300—uterine cancer	2.74e-06	3.97e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CA—uterine cancer	2.62e-06	3.8e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AKT1—uterine cancer	2.14e-06	3.11e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.02e-06	2.93e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AKT1—uterine cancer	1.65e-06	2.4e-05	CbGpPWpGaD
